Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 12, 2020 11:23 ET | Source: Genmab A/S

Genmab Announces Financial Results for the First Half of 2020

August 12, 2020; Copenhagen, Denmark; Interim Report for the First Half of 2020 Highlights ·Genmab and AbbVie enter into broad oncology collaboration; USD 750 million upfront payment with...
July 31, 2020 15:38 ET | Source: Genmab A/S

Genmab Announces European Myeloma Network and Janssen Achieve Positive Topline Results from Phase 3 APOLLO Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Company Announcement Phase 3 APOLLO randomized study evaluating subcutaneous daratumumab in combination with pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in relapsed or...
July 20, 2020 11:57 ET | Source: Genmab A/S

Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 20, 2020 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital...
July 16, 2020 06:43 ET | Source: Genmab A/S

Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020

Company Announcement Net sales of DARZALEX® in the second quarter of 2020 totaled USD 901 millionGenmab will receive royalties on worldwide net sales from Janssen Biotech, Inc. Copenhagen, Denmark;...
July 07, 2020 07:01 ET | Source: Genmab A/S

Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 7, 2020 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets...
July 03, 2020 15:18 ET | Source: Genmab A/S

Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 3, 2020 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets...
July 03, 2020 03:51 ET | Source: Genmab A/S

Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 3, 2020 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets...
June 30, 2020 13:52 ET | Source: Genmab A/S

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement Copenhagen, Denmark; June 30, 2020 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 66,487 shares as a consequence of the exercise of employee warrants. The...
June 29, 2020 16:29 ET | Source: Genmab A/S

Genmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer

Company Announcement Genmab and Seattle Genetics plan to discuss the results with the U.S. Food and Drug Administration (U.S. FDA)Full data to be presented at an upcoming medical meeting Copenhagen,...
June 10, 2020 06:00 ET | Source: Genmab A/S

Genmab and AbbVie Announce Broad Oncology Collaboration

Company Announcement Genmab and AbbVie entered into a broad collaboration to jointly develop and commercialize three of Genmab’s next-generation bispecific antibody products, including...